FDA panel rejects MDMA-based treatment for PTSD
A potential treatment for post-traumatic stress disorder using the hallucinogen MDMA was overwhelmingly rejected by a federal regulatory panel on Tuesday, in what could be a major setback for the use of psychedelics in treating mental illness. A US Food and Drug Administration (FDA) committee voted 10 against approving MDMA as safe for treating PTSD […]